Type:Tablet
Generic Name:Dapsone
Manufacturer:Gaco Pharmaceuticals(G.A Company Ltd)
Price:৳0.00
Pneumonia, Acne, Leprosy, Dermatitis herpetiformis
Dermatitis Herpetiformis 50 mg PO qDay, titrate to 300 mg qDay or higher to achieve desired effect Reduce dose to minimum effective dose within the range of 50-300 mg qDay as soon as possible Leprosy 100 mg PO qDay, in combination with other antileprosy drugs Tuberculoid or Lepromatous Disease 100 mg PO qDay with rifampin 600 mg PO qDay
Child: PO 2 mg/kg, max 100 mg q24h 4 mg/kg, max 200 mg Once weekly
Hypersensitivity. Severe anaemia, porphyria.
Dapsone inhibits folic acid synthesis by preventing normal bacterial utilization of PABA (PABA).
G6PD deficiency, methaemoglobin or Hb M. Perform regular blood counts and monitor liver function regularly. Pregnancy and lactation. Lactation: Enters breast milk; not recommended (AAP Committee states "compatible with nursing")
1-10% Hemolysis,Methemoglobinemia <1% Reactional states (ie, abrupt changes in clinical activity occurring during any leprosy treatment; classified as reversal of erythema nodosum leprosum reactions),Insomnia,Headache,Exfoliative dermatitis,Photosensitivity,Nausea,Vomiting,Anemia,Leukopenia,Agranulocytosis,Hepatitis,Cholestatic jaundice,Peripheral neuropathy (usually in nonleprosy patients),Blurred vision,Tinnitus,SLE Potentially Fatal: Agranulocytosis, serious cutaneous hypersensitivity reactions, exfoliative dermatitis.
Pregnancy category: C Lactation: Enters breast milk; not recommended (AAP Committee states "compatible with nursing")
Decreased serum conc of dapsone when used with rifampicin. Increased plasma conc with probenecid, trimethoprim. Antagonize clofazimine.
